FdUMP is a multimer of FdUMP, a suicide inhibitor of thymidylate synthase (TS), and was designed to bypass resistance to 5-fluorouracil (5FU). The aim of the study was to compare the effect of FdUMP with 5FU and 5-fluoro-2-deoxyuridine (FUdR) in their efficacy to inhibit their target TS in resistant cells. Therefore cell lines FM3A/0, FM3A/TK - (deficient in thymidine kinase) and FM3A/TS-(deficient in thymidylate synthase) were used to determine TK dependency and specificity for TS inhibition. FdUMP inhibited cell growth with greater potency than 5FU and FdUMP. Direct folate-based inhibitors Raltitrexed, GW1843U89 and Pemetrexed were also evaluated using these cell lines. In TK-deficient cells these folate-based inhibitors had greater potency than the fluoropyrimidines (FPs). Surprisingly, Pemetrexed even inhibited cell growth in TS-deficient cells. Incubation with nucleotidase and phosphatase inhibitors resulted in a reduction of cytotoxicity of FdUMP, indicating that the drug can be degraded outside the cells. In the TS in situ inhibition assay (TSIA) 24 h exposure of FM3A cells to 0.5 μM FdUMP and 0.05 μM FdUMP decreased TSIA to 7 and 1% of control. Inhibition of nucleotidase and phosphatase activities reduced the effect of FdUMP, while the inhibitory effect was lower in cells lacking TK. FdUMP can enter the cells intact, but also to some extent after dephosphorylation. In conclusion, FdUMP can bypass resistance to FUdR by direct inhibition of TS.
|Publication status||Published - 2007|
Bijnsdorp, I. V., Comijn, E. M., Padron, J. M., Gmeiner, W. H., & Peters, G. J. (2007). Mechanisms of action of FdUMP: Metabolite activation and thymidylate synthase inhibition. Oncology Reports, 18(1), 287-291.